S
Sam Salek
Researcher at University of Hertfordshire
Publications - 175
Citations - 3024
Sam Salek is an academic researcher from University of Hertfordshire. The author has contributed to research in topics: Medicine & Quality of life (healthcare). The author has an hindex of 23, co-authored 149 publications receiving 2247 citations. Previous affiliations of Sam Salek include Cardiff University & The Hertz Corporation.
Papers
More filters
Journal ArticleDOI
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Florence J Dalgard,Uwe Gieler,Lucia Tomas-Aragones,Lars Lien,Françoise Poot,Gregor B.E. Jemec,Laurent Misery,Csanád Szabó,Dennis Linder,Francesca Sampogna,Andrea W M Evers,Jon Anders Halvorsen,Flora Balieva,Jacek C Szepietowski,Dmitry Romanov,Servando E Marron,İlknur Kıvanç Altunay,Andrew Yule Finlay,Sam Salek,Jörg Kupfer +19 more
TL;DR: The association with depression and anxiety was highest for patients with psoriasis, atopic dermatitis, hand eczema, and leg ulcers, and only patients with Psoriasis had significant association with suicidal ideation.
Journal ArticleDOI
A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease
TL;DR: The need for HR-QOL tools such as the EuroQol-5D to be used together with disease-specific tools to provide the most comprehensive picture of the costs and impact of PD is highlighted.
Journal ArticleDOI
Emerging Guidelines for Patient Engagement in Research
John R. Kirwan,Maarten de Wit,Lori Frank,Kirstie L. Haywood,Sam Salek,Samantha J. Brace-McDonnell,Anne Lyddiatt,Skye Barbic,Jordi Alonso,Francis Guillemin,Susan J. Bartlett +10 more
TL;DR: Different experiences of integrating patients as full patient research partners in outcomes research from multiple perspectives are described, drawing from three real-world examples, to suggest basic guidelines for outcomes researchers on establishing research partnerships with patients.
Journal ArticleDOI
A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis.
TL;DR: The aim of the study was to develop a new model for benefit‐risk assessment of medicines using multi‐criteria decision analysis (MCDA), which is widely used by regulatory authorities or industry.
Journal ArticleDOI
Equivalence of electronic and paper-based patient-reported outcome measures
TL;DR: Electronic formats of paper-based patient-reported outcomes (PROs) should be validated before they can be reliably used and this literature review gives encouragement to the further widespread development and use of ePROs.